Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Yelena Janjigian, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Cancer Center
Duarte, California, United States
- Memorial Cancer Institute
Pembroke Pines, Florida, United States
- Piedmont Hospital Research Institute
Atlanta, Georgia, United States
- Nebraska Cancer Specialists, Methodist Estabrook Cancer Center
Omaha, Nebraska, United States
- Memoral Sloan Kettering Cancer Center
Basking Ridge, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center @ Suffolk
Commack, New York, United States
- Queens Cancer Center of Queens Hospital
Jamaica, New York, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- Memorial Sloan Kettering Cancer Center 1275 York Avenue
New York, New York, United States
- Weill Medical College of Cornell University
New York, New York, United States
- Memorial Sloan Kettering at Mercy Medical Center
Rockville Centre, New York, United States
- Memoral Sloan Kettering Cancer Center@phelps Memorial Hospital
Sleepy Hollow, New York, United States
- University Hospital of Cleveland
Cleveland, Ohio, United States
- University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Oct 2006
- Primary completion
- 26 Oct 2018
- Completion
- 26 Oct 2018
- Last update posted
- 10 Dec 2019
- Registered enrollment
- 111
- Registry id
- NCT00515411
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.